FDA issues Viagra ad warning letter

Share this article:
The FDA issued a warning letter to Pfizer for not mentioning the risks of impotence pill Viagra in a video ad on CNN.com.
 
The 30-second video showed a group of musicians singing “Viva Viagra” in a song about the benefits of the drug.

Pfizer said in published reports that a technical issue with the CNN website prevented the risk information from being displayed on a banner to accompany the video and that it has since pulled the ad.

“Pfizer discovered the error, notified the website of the error, and our understanding was that the website corrected its error immediately,” the company said in a statement.

Drugmakers are required to mention a drug's negative side effects in any advertisement that highlights benefits. Viagra's label warns of potential risks to patients with existing heart conditions as well as reported headaches and abnormal vision.

The FDA warning letter was dated April 16 and posted to the FDA's website April 21.

In the letter, DDMAC director Thomas Abrams wrote the Viagra ad “raises public health and safety concerns through its complete omission of risk information for Viagra.”
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.